January 28, 2022
261
3
1
1.53%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
15:14Now PlayingOn the Urban Debate, with Heena Gambhir, we discuss the permission to Bharat Biotech for intranasal booster dose trials in India that has been given by the Drugs Controller General of India (DCGI). The trials will be done at nine different sites. The Hyderabad-based manufacturer had proposed the booster dose for those who have been already been inoculated with Covishield and Covaxin vaccines. Bharat Biotech aims to conduct clinical trials on 5,000 healthy subjects: half or 2,500 individuals who have received Covishield and another 2,500 who have been administered Covaxin. Heena Gambhir lays down the bare facts before welcoming our guests for the night. We are joined by top experts, Dr Rajib Dasgupta, a member of the national COVID19 task force and Chandrakant Lahariya Health Systems Expert. Watch the full report to know more! #TheUrbanDebate #BoosterDose #HeenaGambhir
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.